KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Astrana Health (ASTH) EBITDA Margin: 2009-2024

Historic EBITDA Margin for Astrana Health (ASTH) over the last 16 years, with FY2024 value amounting to 4.39%.

  • Astrana Health's EBITDA Margin fell 39300.0% to 2.01% in Q3 2025 from the same period last year, while for Sep 2025 it was 2.1%, marking a year-over-year decrease of 28200.0%. This contributed to the annual value of 4.39% for FY2024, which is 17100.0% down from last year.
  • Per Astrana Health's latest filing, its EBITDA Margin stood at 4.39% for FY2024, which was down 17100.0% from 6.1% recorded in FY2023.
  • Astrana Health's EBITDA Margin's 5-year high stood at 12.69% during FY2021, with a 5-year trough of 4.39% in FY2024.
  • Over the past 5 years, Astrana Health's median EBITDA Margin value was 9.11% (recorded in 2022), while the average stood at 8.8%.
  • Its EBITDA Margin has fluctuated over the past 5 years, first skyrocketed by 59300bps in 2020, then plummeted by -35700bps in 2022.
  • Over the past 5 years, Astrana Health's EBITDA Margin (Annual) stood at 11.71% in 2020, then grew by 8bps to 12.69% in 2021, then decreased by -28bps to 9.11% in 2022, then crashed by -33bps to 6.1% in 2023, then fell by -28bps to 4.39% in 2024.
  • Its EBITDA Margin was 4.39% in FY2024, compared to 6.1% in FY2023 and 9.11% in FY2022.